Fox Chase Cancer Center Doctor To Sign Charter of Paris Against Cancer
PHILADELPHIA (January 24, 2000) -- Robert F. Ozols, M.D., Ph.D., Senior Vice President of Medical Science at Fox Chase Cancer Center, will represent Philadelphia as a signer of the Charter of Paris Against Cancer at the World Summit Against Cancer in Paris, France, February 3-4, 2000.
The Charter will be signed on Feb. 4th at Elyse Palace in Paris under the auspices of M. Jacques Chirac, President of the French Republic. Others to sign the Charter include patient advocates, government officials and renowned doctors and researchers from around the world. The signing follows an ecumenical service at the Cathedral de Notre Dame.
The Charter calls for a bold commitment to scientific, social and political innovations that enable the best possible delivery of cancer care, everywhere. To commemorate this monumental call to action and to honor all those who have personally faced cancer, February 4th will be declared World Cancer Day.
"The Charter of Paris Against Cancer is a historic declaration to raise international concern about cancer," said Ozols. "Those of us who sign it are making a global commitment to the worldwide prevention and treatment of cancer. Fox Chase Cancer Center has long supported this philosophy. Our researchers have worked collaboratively for years with scientists from many different countries. We also have a history of providing our state-of-the-art care to international patients who seek care in the United States."
The Charter encompasses ten major directives including: protecting and expanding patient rights; increasing the commitment to basic, clinical and translational research; improving access to clinical trials, prevention and screening programs; and addressing patients' quality of life issues. On February 3rd, the attendees will meet for a daylong conference at the L'Hotel de Ville (Paris City Hall) to identify action items. Nobel Prize winner Elie Wiesel will deliver the welcoming address.
The World Summit Against Cancer is organized by the joint initiative of Gabriel N. Hortobagyi of M.D. Anderson Cancer Center in Houston, Texas and Professor David Khayat, M.D., Ph.D. of the Pitie-Salpetriere Hospital in Paris. The National Cancer Institute, American Cancer Society and American Association for Cancer Research are just a few of the esteemed U.S. organizations that are participating in this endeavor.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at: www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).